Sökning: onr:"swepub:oai:DiVA.org:uu-21980" >
Prasugrel achieves ...
Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease
-
Jernberg, Tomas (författare)
-
Payne, Christopher D. (författare)
-
Winters, Kenneth J. (författare)
-
visa fler...
-
Darstein, Christelle (författare)
-
Brandt, John T. (författare)
-
Jakubowski, Joseph A. (författare)
-
Naganuma, Hideo (författare)
-
- Siegbahn, Agneta, 1947- (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,UCR
-
- Wallentin, Lars, 1943- (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,UCR
-
visa färre...
-
(creator_code:org_t)
- 2006-04-18
- 2006
- Engelska.
-
Ingår i: European Heart Journal. - : Oxford University Press (OUP). - 0195-668X .- 1522-9645. ; 27:10, s. 1166-1173
- Relaterad länk:
-
http://www.ncbi.nlm....
-
visa fler...
-
https://academic.oup...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- AIMS: This study was designed to compare the degree of inhibition of platelet aggregation (IPA) of prasugrel with that of clopidogrel in stable aspirin-treated patients with coronary artery disease (CAD). METHODS AND RESULTS: Subjects (n=101) were randomly assigned to the following loading dose (LD) (day 1)/maintenance dose (MD) (days 2-28) combinations: prasugrel, 40 mg/5 mg; 40 mg/7.5 mg; 60 mg/10 mg; 60 mg/15 mg; or clopidogrel, 300 mg/75 mg. Turbidometric platelet aggregation was measured at multiple timepoints during the study. At 4 h after dosing, with 20 microM ADP, both prasugrel LDs achieved significantly higher mean IPA levels (60.6% and 68.4 vs. 30.0%, respectively; all P<0.0001) and lower percentage (3 vs. 52%, P<0.0001) of pharmacodynamic non-responders (defined as IPA <20%) than clopidogrel. Prasugrel 10 and 15 mg MDs achieved consistently higher mean IPA than clopidogrel 75 mg at day 28 (all P<0.0001). At pre-MD on day 28, there were no non-responders in the 10 and 15 mg prasugrel group, compared with 45% in the clopidogrel group (P=0.0007). CONCLUSION: In this population, prasugrel (40-60 mg LD and 10-15 mg MD) achieves greater IPA and a lower proportion of pharmacodynamic non-responders compared with the approved clopidogrel dosing.
Nyckelord
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Jernberg, Tomas
-
Payne, Christoph ...
-
Winters, Kenneth ...
-
Darstein, Christ ...
-
Brandt, John T.
-
Jakubowski, Jose ...
-
visa fler...
-
Naganuma, Hideo
-
Siegbahn, Agneta ...
-
Wallentin, Lars, ...
-
visa färre...
- Artiklar i publikationen
-
European Heart J ...
- Av lärosätet
-
Uppsala universitet